Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Biogen (Switzerland) | Researchclopedia

Back to institutions

Biogen (Switzerland)

Zugcompany

1,077

Works

110,899

Citations

164

h-index

Top Research Topics

Multiple Sclerosis Research Studies Biosimilars and Bioanalytical Methods Monoclonal and Polyclonal Antibodies Research

Top Researchers

Paul M. Thompson

4,294 works237,061 citationsh-index: 222

Recent Research

LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial

Omar S. Mabrouk,Ben Tichler,et al.

20260 citations

Health Systems, Economic Evaluations, Quality of Life

Systemic Lupus Erythematosus Research

Pharmaceutical studies and practices

Polyomavirus and related diseases

Rheumatoid Arthritis Research and Therapies

Immunotherapy and Immune Responses

RNA and protein synthesis mechanisms

Pharmaceutical Economics and Policy

Computational Drug Discovery Methods

Richard A. Flavell Yale University

1,514 works231,941 citationsh-index: 246

Benjamin L. Ebert RWTH Aachen University

765 works153,393 citationsh-index: 122

Séverine Vermeire KU Leuven

2,394 works110,761 citationsh-index: 163

Stephen R. Bloom Imperial College London

1,419 works104,562 citationsh-index: 155

1,701 works101,369 citationsh-index: 155

Application of protein language models for antibody developability prediction

Samad Amini,Yimin Huang,et al.

20260 citations

Digital patient experience tools in multiple sclerosis: a landscape analysis of the global Patient-Reported Outcomes in Multiple Sclerosis (PROMS) initiative

Vasilis-Spyridon Tseriotis,Liesbet M. Peeters,et al.

20260 citations

Cutaneous Lupus Activity Investigator’s Global Assessment–Revised (CLA-IGA-R) Content Validity: Cutaneous Lupus Erythematosus (CLE) Patient Qualitative Study

Joseph F Merola,W. Yang,et al.

20260 citations

All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity

Victoria P Werth,Joseph F Merola,et al.

20260 citations

PT4:04 Achievement of low disease activity and remission in patients with SLE treated with dapirolizumab pegol: updated 48-week analyses from a phase 3 trial including lower glucocorticoid dose criteria

Eric F Morand,L. M. Carter,et al.

20260 citations